Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%
Earnings

Biorem Reports Record Order Backlog, - $11.3 Million of Revenues in the Quarter and Quarterly EPS of $0.07

By The Northwire Desk — AI Analysis Nov 17, 2025 · 07:59 BRM · 2.15 Biorem Inc.
BRM · Price

Executive Summary

  • Biorem reported Q3 2025 revenue of $11.3 M (up 19% QoQ) and EPS of $0.07, with a record order backlog of $71 M as of September 30, 2025.
  • Net earnings for the quarter were $1.6 M; cash on hand increased to $8.4 M and working capital rose to $11.7 M.
  • The company booked $17 M of new orders during the quarter, projecting continued order‑booking growth and revenue expansion over the next 12 months.

Key Details

  • Revenue: $11,253 k (Q3 2025) vs. $14,886 k (Q3 2024); YTD $25,414 k vs. $28,104 k (2024).
  • Gross Profit: $3,166 k (Q3 2025) – 28% of revenue; down from $5,021 k (33%) in Q3 2024.
  • Operating Expenses: $1,552 k (Q3 2025) vs. $1,992 k (Q3 2024).
  • EBITDA: $1,707 k (Q3 2025) vs. $3,138 k (Q3 2024).
  • Net Earnings: $1,158 k (Q3 2025) vs. $2,192 k (Q3 2024).
  • EPS – Basic: $0.07 (Q3 2025) vs. $0.14 (Q3 2024).
  • EPS – Fully Diluted: $0.06 (Q3 2025) vs. $0.12 (Q3 2024).
  • Order Backlog: Record $71 M on Sep 30, 2025; up from $50.9 M on Jun 30, 2025 and $48.4 M on Sep 30, 2024.
  • New Orders Booked: $17 M during Q3 2025.
  • Cash Position: Cash on hand $8.4 M (Sep 30, 2025); working capital $11.7 M.
  • Operating Cash Flow: Generated $1.7 M of cash; net increase in non‑cash working capital used $0.807 M of cash.

Notable Quotes

“A multi‑pronged effort by the sales team across the various product categories has resulted in strong order bookings and order backlog growth,” said Derek S. Webb, President & CEO.
“With a historic order backlog and continued bookings growth anticipated, Biorem is continuing on its growth trajectory.”

Read the original news release →

More from Biorem Inc.

May 14, 2026 · 08:00

Biorem’s $77 million order mountain signals blue-sky demand, but margin clouds linger

Earnings Apr 20, 2026 · 11:17

Biorem Posts Record Earnings But Backlog Correction Raises Governance Questions

Earnings Apr 20, 2026 · 08:00

Biorem Profits Soar on Margin Expansion as Cash Reserves Double

Earnings Nov 17, 2025 · 17:34

Biorem earns $1.15-million in Q3 2025

Earnings